chr12-55724427-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_002905.5(RDH5):c.839G>A(p.Arg280His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000911 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000090 ( 0 hom. )
Consequence
RDH5
NM_002905.5 missense
NM_002905.5 missense
Scores
11
5
3
Clinical Significance
Conservation
PhyloP100: 8.07
Genes affected
RDH5 (HGNC:9940): (retinol dehydrogenase 5) This gene encodes an enzyme belonging to the short-chain dehydrogenases/reductases (SDR) family. This retinol dehydrogenase functions to catalyze the final step in the biosynthesis of 11-cis retinaldehyde, which is the universal chromophore of visual pigments. Mutations in this gene cause autosomal recessive fundus albipunctatus, a rare form of night blindness that is characterized by a delay in the regeneration of cone and rod photopigments. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring upstream BLOC1S1 (biogenesis of lysosomal organelles complex-1, subunit 1) gene. [provided by RefSeq, Dec 2010]
CD63 (HGNC:1692): (CD63 molecule) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The encoded protein is a cell surface glycoprotein that is known to complex with integrins. It may function as a blood platelet activation marker. Deficiency of this protein is associated with Hermansky-Pudlak syndrome. Also this gene has been associated with tumor progression. Alternative splicing results in multiple transcript variants encoding different protein isoforms. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a topological_domain Lumenal (size 266) in uniprot entity RDH5_HUMAN there are 57 pathogenic changes around while only 2 benign (97%) in NM_002905.5
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-55724427-G-A is Pathogenic according to our data. Variant chr12-55724427-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 8005.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-55724427-G-A is described in Lovd as [Likely_pathogenic]. Variant chr12-55724427-G-A is described in Lovd as [Pathogenic]. Variant chr12-55724427-G-A is described in Lovd as [Pathogenic]. Variant chr12-55724427-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RDH5 | NM_002905.5 | c.839G>A | p.Arg280His | missense_variant | 5/5 | ENST00000257895.10 | NP_002896.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RDH5 | ENST00000257895.10 | c.839G>A | p.Arg280His | missense_variant | 5/5 | 1 | NM_002905.5 | ENSP00000257895.6 | ||
ENSG00000258311 | ENST00000550412.5 | c.*2721G>A | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000447650.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152156Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251414Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135886
GnomAD3 exomes
AF:
AC:
21
AN:
251414
Hom.:
AF XY:
AC XY:
12
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.0000921 AC XY: 67AN XY: 727218
GnomAD4 exome
AF:
AC:
131
AN:
1461852
Hom.:
Cov.:
31
AF XY:
AC XY:
67
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74342
GnomAD4 genome
AF:
AC:
16
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 280 of the RDH5 protein (p.Arg280His). This variant is present in population databases (rs62638193, gnomAD 0.03%). This missense change has been observed in individual(s) with fundus albipunctatus (PMID: 10617778, 11053295, 15007239). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8005). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RDH5 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects RDH5 function (PMID: 11675386). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 29, 2016 | - - |
Pigmentary retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 11, 2018 | The RDH5 c.839G>A (p.Arg280His) missense variant has been reported in at least five studies in which is found in a compound heterozygous state in a total of eight individuals with fundus albipunctatus (FA) (including one set of monozygotic twins and a pair of siblings) and in a heterozygous state in three unaffected family members (Gonzalez-Fernandez et al. 1999; Nakamura et al. 2000; Kuroiwa et al. 2000; Sato et al. 2004; Nakamura et al. 2004). The p.Arg280His variant was absent from 310 control alleles but is reported at a frequency of 0.000349 in the Latino population of the Genome Aggregation Database. The p.Arg280His variant is located in the catalytic domain of the protein. Functional studies in COS-1 cells showed that the variant resulted in 2% protein expression and less than 1% enzyme activity compared to wild type (Lidén et al. 2001). Co-expression studies showed the reduction of enzyme activity was dose-dependent. The variant is suggested to have a dominant-negative effect (Lidén et al. 2001). Based on the collective evidence, the p.Arg280His variant is classified as pathogenic for fundus albipunctatus. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Fundus albipunctatus, autosomal recessive Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2000 | - - |
Congenital stationary night blindness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | Jul 24, 2023 | Clinical significance based on ACMG v2.0 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;.;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Benign
T;T;T
Sift4G
Uncertain
D;T;T
Polyphen
1.0
.;D;D
Vest4
MVP
MPC
0.55
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at